Name | Eukaryotic translation initiation factor 4E-binding protein 1 | ||
UniProt ID | 4EBP1_HUMAN | ||
Gene Name | EIF4EBP1 | ||
Gene ID | 1978 | ||
Synonyms |
EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I
|
||
Sequence |
MSGGSSCSQTPSRAIPATRRVVLGDGVQLPPGDYSTTPGGTLFSTTPGGTRIIYDRKFLM
ECRNSPVTKTPPRDLPTIPGVTSPSSDEPPMEASQSHLRNSPEDKRAGGEESQFEMDI |
||
Pathway Map | MAP LINK | ||
KEGG ID | hsa1978 | ||
TTD ID | T84941 | ||
Pfam | PF05456 |
Pair Name | Brusatol, Cabergoline | |||
Phytochemical | Brusatol | |||
Drug | Cabergoline | |||
Disease Info | [ICD-11: 2F37] | Pituitary adenomas | Investigative | |
Regulate Info | Down-regulation | Eukaryotic translation initiation factor 4E-binding protein 1 | Phosphorylation | |
Result | Combined use of CAB and BT may increase the clinical effectiveness of treatment for human pituitary adenomas. |
Pair Name | Fangchinoline, Everolimus | |||
Phytochemical | Fangchinoline | |||
Drug | Everolimus | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Regulate Info | Down-regulation | Eukaryotic translation initiation factor 4E-binding protein 1 | Phosphorylation | |
Result | Firstly link CHOP to Notch 3/c-MYC axis-dependent apoptosis and provide the Notch 3/c-MYC/CHOP activation as a promising strategy for mTOR-targeted combination therapy in lung cancer treatment. |
Pair Name | Fisetin, Fluorouracil | |||
Phytochemical | Fisetin | |||
Drug | Fluorouracil | |||
Disease Info | [ICD-11: 2B91] | Colorectal cancer | Investigative | |
Regulate Info | Down-regulation | Eukaryotic translation initiation factor 4E-binding protein 1 | Phosphorylation | |
Result | Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer |
No. | Title | Href |
---|---|---|
1 | Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas. Oxid Med Cell Longev. 2021 Jun 16;2021:6696015. doi: 10.1155/2021/6696015. | Click |
2 | Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus. Biochem Pharmacol. 2020 May;175:113921. doi: 10.1016/j.bcp.2020.113921. | Click |
3 | Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer. Int J Cancer. 2019 Dec 1;145(11):3022-3032. doi: 10.1002/ijc.32367. | Click |